(19)
(11) EP 1 351 689 A2

(12)

(88) Date of publication A3:
24.07.2003

(43) Date of publication:
15.10.2003 Bulletin 2003/42

(21) Application number: 01274482.7

(22) Date of filing: 19.12.2001
(51) International Patent Classification (IPC)7A61K 31/4725
(86) International application number:
PCT/US0145/858
(87) International publication number:
WO 0302/4934 (27.03.2003 Gazette 2003/13)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 05.01.2001 EP 01500003

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • BLEISCH, Thomas, John
    Noblesville, IN 46060 (US)
  • CASTANO MANSANET, Ana, Maria,Lilly, S.A.
    E-28100 Alcobendas (ES)
  • DOMINGUEZ-MANZANARES, Esteban,Lilly, S.A.
    E-28100 Alcobendas (ES)
  • ESCRIBANO, Ana, Maria,Lilly, S.A.
    E-28100 Alcobendas (ES)
  • ORNSTEIN, Paul, Leslie
    Carmel, IN 46032 (US)

(74) Representative: Kingsbury, Oliver William 
Eli Lilly and Company Limited,Erl Wood Manor,Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) DERIVATIVES OF THE (3S, 4AR, 6S, 8AR) 6-PHENYLAMINO-1,2,3,4,4A,5,6,7,8,8A-DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AS EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES